Health

PAM Health Announces Plans to Build 42-bed Rehab Hospital in Minneola, Florida
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Lawsuit - NVO
Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA
Newfound Circuit Better Explains How the Brain Recognizes What Is Familiar and Important
Mediwaste Becomes remedi: The Future of Medical Waste is Here
WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year
Dr. Anupama Shetty Appointed Neonatal Intensive Care Unit Medical Director at Miller Children's & Women's Hospital
LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
NIPPON EXPRESS HOLDINGS schließt Verfahren zur Umwandlung der deutschen SH HoldCo in eine hundertprozentige Tochtergesellschaft ab
NIPPON EXPRESS HOLDINGS achève la procédure visant à faire de la société allemande SH HoldCo une filiale à 100 %.
VIVOZON Pharmaceutical Obtains MFDS Approval for UNAFRA Inj.: A Breakthrough Non-Opioid analgesic
VIVOZON Pharmaceutical erhält MFDS-Zulassung für UNAFRA Inj.: Ein bahnbrechendes nicht-opioides Analgetikum
VIVOZON Pharmaceutical obtiene la aprobación del MFDS para UNAFRA Inj.: un analgésico innovador no opioide
VIVOZON Pharmaceutical obtient l'autorisation du MFDS pour UNAFRA Inj. : un analgésique non opioïdes révolutionnaire
Enzymatica AB Year-end report 2024: Strong performance in core markets - preparing for international growth
SBTi Verifies GenScript Biotech Corp's Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone!
Leqembi® sales reaches €200 million - first sales milestone achieved
CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026
NIPPON EXPRESS HOLDINGS convierte a SH HoldCo de Alemania en una filial de su entera propiedad
Coway Unveils Corporate Value-Up Plan with Revenue Target of KRW 5 Trillion in 2027